PapersPMID:40655486
Effects of spirulina supplementation alone or with exercise on cardiometabolic health in overweight and obese adults: a systematic review and meta-analysis.
- findings
- 10
- compound
- 1
- endpoints
- 9
- no difference found
- 4
- Study, every finding
- meta-analysis
What moved
How to read these marks →“Spirulina significantly lowered TC (N = 13, g = −0.79, 95% CI: −1.18 to −0.41, I2 = 76%, p < 0.01, low GRADE), TG (N = 13, g = −0.64, 95% CI: −1.00 to −0.28, I2 = 74%, p < 0.01, low GRADE), and LDL-C (N = 13, g = −0.71, 95% CI: −1.13 to −0.29, I2 = 80%, p < 0.01, moderate GRADE), while increasing HDL-C (N = 13, g = 0.53, 95% CI: 0.04 to 1.02, I2 = 86%, p = 0.03, very low GRADE).”
- Decreases triglycerides
moderatereplicated ×4
- Effect
- −0.64 standardised mean difference, 95% CI −1 to −0.28
- Dose studied
- 0.02 to 10 g/day, 2 to 24 weeks, pooled
- Population
- Overweight or obese adults (BMI 25-40 kg/m2, aged 26-65 years) in the 21 trials (867 participants) of spirulina alone against placebo or no intervention; 13 trials contributed to this estimate
- Effect
- −0.79 standardised mean difference, 95% CI −1.18 to −0.41
- Dose studied
- 0.02 to 10 g/day, 2 to 24 weeks, pooled
- Population
- Overweight or obese adults (BMI 25-40 kg/m2, aged 26-65 years) in the 21 trials (867 participants) of spirulina alone against placebo or no intervention; 13 trials contributed to this estimate
- Decreases LDL cholesterol
limited
- Effect
- −0.71 standardised mean difference, 95% CI −1.13 to −0.29
- Dose studied
- 0.02 to 10 g/day, 2 to 24 weeks, pooled
- Population
- Overweight or obese adults (BMI 25-40 kg/m2, aged 26-65 years) in the 21 trials (867 participants) of spirulina alone against placebo or no intervention; 13 trials contributed to this estimate
- Increases HDL cholesterol
limited
- Effect
- 0.53 standardised mean difference, 95% CI 0.04 to 1.02
- Dose studied
- 0.02 to 10 g/day, 2 to 24 weeks, pooled
- Population
- Overweight or obese adults (BMI 25-40 kg/m2, aged 26-65 years) in the 21 trials (867 participants) of spirulina alone against placebo or no intervention; 13 trials contributed to this estimate
- Decreases diastolic blood pressure
moderatereplicated ×2
“Spirulina significantly reduced DBP (N = 4, g = −0.73, 95% CI: −1.43 to −0.03, I2 = 83%, p = 0.04, very low GRADE) and showed a trend toward reducing SBP (N = 4, g = −1.06, 95% CI: −2.23 to 0.10, I2 = 93%, p = 0.07, very low GRADE).”
- Effect
- −0.73 standardised mean difference, 95% CI −1.43 to −0.03
- Dose studied
- 0.02 to 10 g/day, 2 to 24 weeks, pooled
- Population
- Overweight or obese adults (BMI 25-40 kg/m2, aged 26-65 years) in the 21 trials (867 participants) of spirulina alone against placebo or no intervention; four trials contributed to this estimate
- Decreases body mass
limited
“Spirulina significantly reduced BW compared to controls (N = 8, g = −0.30, 95% CI: −0.53 to −0.08, I2 = 15%, p < 0.01, low GRADE).”
- Effect
- −0.3 standardised mean difference, 95% CI −0.53 to −0.08
- Dose studied
- 0.02 to 10 g/day, 2 to 24 weeks, pooled
- Population
- Overweight or obese adults (BMI 25-40 kg/m2, aged 26-65 years) in the 21 trials (867 participants) of spirulina alone against placebo or no intervention; eight trials contributed to this estimate
What did not
“Compared to placebo + exercise, Spirulina combined with exercise showed no significant effects on BW (N = 4, g = 0.01, 95% CI: −0.40 to 0.42, I2 = 0%, p = 0.95, low GRADE), BMI (N = 5, g = −0.54, 95% CI: −1.42 to 0.35, I2 = 79%, p = 0.24, very low GRADE), BFP (N = 4, g = −0.12, 95% CI: −0.52 to 0.28, I2 = 0%, p = 0.55, low GRADE), or VO2max (N = 3, g = 0.27, 95% CI: −0.20 to 0.74, I2 = 0%, p = 0.26, low GRADE).”
- No detected effect on body mass
moderatereplicated ×2
- Effect
- 0.01 standardised mean difference, 95% CI −0.4 to 0.42
- Dose studied
- 1 to 6 g/day, 4 to 12 weeks, pooled
- Population
- Overweight or obese adults (BMI 28-33 kg/m2, aged 21-62 years, no other comorbidities) in the 7 trials (168 participants) of spirulina plus exercise against placebo plus the same exercise; exercise is background in both arms; four trials contributed to this estimate
- No detected effect on body mass index
moderatereplicated ×2
- Effect
- −0.54 standardised mean difference, 95% CI −1.42 to 0.35
- Dose studied
- 1 to 6 g/day, 4 to 12 weeks, pooled
- Population
- Overweight or obese adults (BMI 28-33 kg/m2, aged 21-62 years, no other comorbidities) in the 7 trials (168 participants) of spirulina plus exercise against placebo plus the same exercise; exercise is background in both arms; five trials contributed to this estimate
- Effect
- 0.27 standardised mean difference, 95% CI −0.2 to 0.74
- Dose studied
- 1 to 6 g/day, 4 to 12 weeks, pooled
- Population
- Overweight or obese adults (BMI 28-33 kg/m2, aged 21-62 years, no other comorbidities) in the 7 trials (168 participants) of spirulina plus exercise against placebo plus the same exercise; exercise is background in both arms; three trials contributed to this estimate
- No detected effect on fasting blood glucose
moderatereplicated ×2
“Spirulina showed no significant effect on FBG (N = 9, g = −0.26, 95% CI: −0.75 to 0.23, I2 = 80%, p = 0.29, very low GRADE) or INS (N = 4, g = −0.69, 95% CI: −1.62 to 0.24, I2 = 84%, p = 0.15, very low GRADE).”
- Effect
- −0.26 standardised mean difference, 95% CI −0.75 to 0.23
- Dose studied
- 0.02 to 10 g/day, 2 to 24 weeks, pooled
- Population
- Overweight or obese adults (BMI 25-40 kg/m2, aged 26-65 years) in the 21 trials (867 participants) of spirulina alone against placebo or no intervention; nine trials contributed to this estimate
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Overweight or obese adults (BMI > 25 kg/m2), some with type 2 diabetes, hypertension, metabolic syndrome, HIV on ART or ulcerative colitis
- Participants
- 1,035
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 46